Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices

About this resource:

HHS Non-systematic Review

Source: Centers for Disease Control and Prevention

Last Reviewed: January 2018

The Advisory Committee on Immunization Practices recommends: 

  • Universal hepatitis B vaccination within 24 hours of birth for medically stable infants
  • Hepatitis B testing for pregnant women who test positive for the hepatitis B antigen
  • Postvaccination blood testing for infants whose mother’s hepatitis B status will be unknown for the foreseeable future (e.g., when a parent with custody surrenders an infant after birth)
  • Single-dose revaccination for infants whose mothers test positive for the hepatitis B antigen and don’t respond to the initial vaccine series
  • Vaccination of people with chronic liver disease
  • Removal of language in the recommendations that seems permissive of delaying infant vaccination until after hospital discharge

This report merges and updates previous recommendations for preventing hepatitis B in the United States.

Read more about this resource

Objectives related to this resource (1)

Suggested Citation

1.

Schillie S, Vellozzi C, Reingold A, et al. (2018). Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. Retrieved from https://www.cdc.gov/mmwr/volumes/67/rr/rr6701a1.htm